WB
IPCI

Webster Bank’s Intellipharmaceuticals International Inc. IPCI Stock Holding History

Webster Bank’s Portfolio IPCI Stock Details IPCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1
Closed – – 612
2016
Q4 		$0 Buy
+1
New +$28 ﹤0.01% 595

Other funds holding IPCI

Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
FFA
First Foundation Advisors Irvine, California $2.48B AUM 18.56% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ATC
Argent Trust Co Nashville, Tennessee $2.95B AUM 22.66% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Webster Bank's IPCI Position: Q1 2017 in Review

Webster Bank sold out of Intellipharmaceuticals International Inc. (IPCI) in Q1 2017, closing a stake of 1 share.

Webster Bank first reported a position in IPCI in Q4 2016 and held it in 1 quarter. The position peaked at $0 in Q4 2016. 22 funds tracked by Wall St. Rank hold IPCI as of Q1 2017.

  • Webster Bank reported no remaining Intellipharmaceuticals International Inc. position as of Q1 2017 after selling out during the quarter.
  • Webster Bank sold 1 Intellipharmaceuticals International Inc. share in Q1 2017.
  • Webster Bank first reported a position in Intellipharmaceuticals International Inc. in Q4 2016 and held it in 1 quarter.
  • Webster Bank's Intellipharmaceuticals International Inc. position peaked at $0 in Q4 2016.
  • 22 funds tracked by Wall St. Rank held Intellipharmaceuticals International Inc. as of Q1 2017.

Based on Webster Bank's 13F filing for Q1 2017, filed 1 May 2017.